Sign in

CIK 0001802768

  • Large accelerated filer

Royalty Pharma plc

Sign in to watch
Ticker
RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+1 212-883-0200
Business address
110 EAST 59TH STREET, NEW YORK, NY, 10022
  1. 4 Grant or award Director acquired 1,384 shares (grant or award)
  2. 4 Grant or award Director acquired 1,384 shares (grant or award)
  3. 4 Planned sale EVP & CFO sold 75,000 shares at an average $30.73 ($2,305,028)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Planned sale EVP & CFO sold 75,000 shares at an average $31.00 ($2,325,214)
  8. 4 Grant or award Director acquired 1,208 shares (grant or award)
  9. 4 Grant or award Director acquired 1,208 shares (grant or award)
  10. 4 Open-market buy CEO, Chairman of the Board bought 130,000 shares at $29.51 ($3,836,768)
  11. 4 Grant or award Director acquired 7,747 shares (grant or award)
  12. 4 Grant or award Director acquired 7,747 shares (grant or award)
  13. 4 Grant or award Director acquired 7,747 shares (grant or award)
  14. 4 Grant or award Director acquired 7,747 shares (grant or award)
  15. 4 Grant or award Director acquired 7,747 shares (grant or award)
  16. 4 Grant or award Director acquired 7,747 shares (grant or award)
  17. 4 Grant or award Director acquired 7,747 shares (grant or award)
  18. 4 Grant or award Director acquired 7,747 shares (grant or award)
  19. 4 Grant or award Director acquired 7,747 shares (grant or award)
  20. 4 Open-market buy CEO, Chairman of the Board bought 90,000 shares at an average $32.89 ($2,959,848)

Page 8 of 18 · 342 filings